Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteoporosis, Postmenopausal × LY 353381 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3 Ovarian Neoplasms 1 Osteoporosis, Postmenopausal 1 Neoplasms 1 Endometrial Neoplasms 1

Interventions

Weights and Measures 1 Risedronic Acid 1 Resistance Training 1 LY 353381 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00088010 2010-06-02

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Eli Lilly and Company

Phase 3 Completed

Osteoporosis, Postmenopausal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡